Technology is growing rapidly and the integration of mobile software’s speculated to be picking pace. In recent news From Patients daily, it was reported that Mindstrong Health had secured $14 million dollars funding for the upgrade of medical plans. Investors such as Foresite Capital, ARCH Venture Partners, and One Mind Brain Health Impact Fund took part in the series-A funding. The funding was meant to improve on various methods of treating brain ailments. These methods would incorporate the use of the sophisticated technology introduced by Foresite Capital. The technology involved the integration of smartphones to diagnose and aid in the treatment of neuropsychiatric disorders. Visit pelotontherapeutics.com
Business Wire, revealed that Mindstrong technology uses brain cognition function to monitor patterns of interaction on Smartphone devices in an objective of measuring the brain function. The company’s aim is to provide continuous digital bookmakers using the function of mood and cognition. Mindstrong Health founding team was echoed to have brought an unmatched understanding in the critical challenges affecting the way medical communities administer their treatments. Foresite CEO, Jim Tananbaum remarked that, the modernized move was one of the best medical approaches in history. He also added that the innovative platform paved way for further discovery and improvements in the future.
About Jim Tananbaum
In a report by INC42, Jim Tananbau is the founder, president and CEO of Foresite Capital based in San Francisco. He is an industry leader with over 25 years experience in healthcare entrepreneur. His focus is based on strategic operational and financial opportunities in healthcare businesses. Prior to founding Foresite, Tananbaum was the co-founder of GelTex Pharmaceuticals, co-founder of Theravance, and Prospect Venture Partners. His company provides growth capital to emerging healthcare sectors from both private and public markets. During his 25 years experience, Tananbaum has founded and helped in the growth of healthcare franchises in all healthcare sectors.
Jim graduated from Yale University with a BS/BSEE degree and earned an M.D. and an M.B.A. from the University of Harvard. He later furthered his studies in Massachusetts Institute of Technology where he earned an M.S. His successful career has made him one of the richest investors in the world.